BlackRock Institutional Trust’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-600,132
| Closed | -$1.78M | – | 3895 |
|
2016
Q3 | $1.78M | Sell |
600,132
-10,539
| -2% | -$31.3K | ﹤0.01% | 3092 |
|
2016
Q2 | $910K | Sell |
610,671
-153,495
| -20% | -$229K | ﹤0.01% | 3333 |
|
2016
Q1 | $2.83M | Sell |
764,166
-1,361
| -0.2% | -$5.04K | ﹤0.01% | 2898 |
|
2015
Q4 | $7.73M | Buy |
765,527
+12,300
| +2% | +$124K | ﹤0.01% | 2489 |
|
2015
Q3 | $10.2M | Buy |
753,227
+12,686
| +2% | +$173K | ﹤0.01% | 2283 |
|
2015
Q2 | $14M | Sell |
740,541
-67,424
| -8% | -$1.28M | ﹤0.01% | 2170 |
|
2015
Q1 | $21.1M | Sell |
807,965
-30
| -0% | -$785 | ﹤0.01% | 1893 |
|
2014
Q4 | $16.9M | Sell |
807,995
-47,835
| -6% | -$1M | ﹤0.01% | 2011 |
|
2014
Q3 | $28.6M | Buy |
855,830
+53,752
| +7% | +$1.79M | ﹤0.01% | 1650 |
|
2014
Q2 | $25.7M | Buy |
802,078
+40,866
| +5% | +$1.31M | ﹤0.01% | 1779 |
|
2014
Q1 | $35.2M | Buy |
761,212
+30,852
| +4% | +$1.42M | 0.01% | 1558 |
|
2013
Q4 | $51.8M | Buy |
730,360
+72,114
| +11% | +$5.12M | 0.01% | 1225 |
|
2013
Q3 | $56.4M | Buy |
658,246
+66,468
| +11% | +$5.7M | 0.01% | 1127 |
|
2013
Q2 | $37.5M | Buy |
+591,778
| New | +$37.5M | 0.01% | 1345 |
|